|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
88
|
300
|
9j8tA |
Crystal structure of sars-cov-2 main protease in complex with mp-4l2 |
|
82
|
301
|
9j8uA |
Crystal structure of sars-cov-2 main protease in complex with mp-4d7 |
|
235
|
926
|
9immA |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
248
|
926
|
9imkA |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
85
|
300
|
9ippA |
Crystal structure of mers main protease in complex with carmofur |
|
171
|
592
|
9immE |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
180
|
592
|
9imkE |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
17
|
113
|
9immG |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
17
|
113
|
9imkG |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
22
|
72
|
9immC |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
48
|
187
|
9immB |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
25
|
72
|
9imkC |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
47
|
187
|
9imkB |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
192
|
592
|
9i53A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with atp |
|
196
|
592
|
9i51A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with adp |
|
68
|
236
|
9i77A |
Deubiquitinase dub16 from leishmania donovani |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
88
|
306
|
9ghnA |
Structure of sars-cov-2 main protease (mpro) with mutation of q256a |
|
79
|
305
|
9ghoA |
Structure of sars-cov-2 main protease (mpro) with mutation of s284a |
|
84
|
301
|
9gi6A |
Structure of sars-cov-2 main protease (mpro) with mutation of n214a |
|
35
|
131
|
9fwqA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00218 |
|
35
|
131
|
9fwsA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
34
|
130
|
9fwhA |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
83
|
302
|
9g0hA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17a |
|
74
|
286
|
9fwsB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
71
|
286
|
9fwhB |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
83
|
302
|
9g0iA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17b |
|
36
|
131
|
9fwpA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00198 |
|
74
|
286
|
9fwmB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00180 |
|
35
|
131
|
9fwrA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
|
70
|
285
|
9fwrB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
|
69
|
285
|
9fwpB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00198 |
|
35
|
131
|
9fwlA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00167 |
|
71
|
286
|
9fwiB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00025 |
|
71
|
285
|
9fwqB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00218 |
|
72
|
286
|
9fwnB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00219 |
|
69
|
285
|
9fwoB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00216 |
|
71
|
286
|
9fwkB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00123 |
|
36
|
131
|
9fwiA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00025 |
|
35
|
131
|
9fwuA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00421 |
|
36
|
131
|
9fwtA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00259 |
|
36
|
131
|
9fwmA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00180 |
|
36
|
131
|
9fwjA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00079 |
|
74
|
286
|
9fwtB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00259 |
|
34
|
131
|
9fwnA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00219 |
|
36
|
131
|
9fwkA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00123 |
